M. Christian

ZNF366 is a novel corepressor for estrogen receptor alpha that mediates its effects through interaction with CtBP (2008)

Ali, S, Periyasamy, M, Lopez-Garcia, J, Thomas, RS, Christian, M, Parker, MG, ...

No abstract available.

Incremental Learning for Motion Prediction of Pedestrians and Vehicles (2008)

Spécialité Imagerie, Alejandro Dizan, Vasquez Govea, M. Augustin, Lux Président, M. Roland, ...

N o attribué par la bibliothèque

Composition du Jury (2007)

Docteur De L’inpg, Spécialité Imagerie, Kenneth Sundaraj, Directeur De Thèse, Christian Laugier, M. Augustin, ...

présentée et soutenue publiquement par

Measurement of oro-cecal transit time in young children using lactose [C-13] ureide requires further validation (2002)

Christian, M., Morrison, D., Dodson, B., Preston, T., Amarri, S., Franchini, F., ...

No abstract available.

D*+- meson production in deep inelastic diffractive interactions at HERA (2001)

...

Measurement of oro-cecal transit time in young children using lactose [C-13] ureide requires further validation

Christian, M., Morrison, D., Dodson, B., Preston, T., Amarri, S., Franchini, F., ...

No abstract available.

Measurement of oro-cecal transit time in young children using lactose [C-13] ureide requires further validation

Christian, M., Morrison, D., Dodson, B., Preston, T., Amarri, S., Franchini, F., ...

No abstract available.

Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography

Christian, M, McColl, J, MacKenzie, J, Beattie, T

AIMS—To address some of the issues in the ongoing debate over the optimal diagnostic imaging following childhood urinary tract infection (UTI), by determining the risk of missing renal cortical...

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

Johnson, J I, Decker, S, Zaharevitz, D, Rubinstein, L V, Venditti, J M, Schepartz, S, ...

An analysis of the activity of compounds tested in pre-clinical in vivo and in vitro assays by the National Cancer Institute's Developmental Therapeutics Program was performed. For 39 agents with...